SG11201405018VA - A composition having antiviral activity against flavivirus - Google Patents
A composition having antiviral activity against flavivirusInfo
- Publication number
- SG11201405018VA SG11201405018VA SG11201405018VA SG11201405018VA SG11201405018VA SG 11201405018V A SG11201405018V A SG 11201405018VA SG 11201405018V A SG11201405018V A SG 11201405018VA SG 11201405018V A SG11201405018V A SG 11201405018VA SG 11201405018V A SG11201405018V A SG 11201405018VA
- Authority
- SG
- Singapore
- Prior art keywords
- composition
- activity against
- antiviral activity
- against flavivirus
- flavivirus
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
- A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| MYPI2012700140 | 2012-03-30 | ||
| PCT/MY2013/000019 WO2013147585A1 (en) | 2012-03-30 | 2013-01-31 | A composition having antiviral activity against flavivirus |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11201405018VA true SG11201405018VA (en) | 2014-09-26 |
Family
ID=49260741
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201405018VA SG11201405018VA (en) | 2012-03-30 | 2013-01-31 | A composition having antiviral activity against flavivirus |
Country Status (4)
| Country | Link |
|---|---|
| US (2) | US20150080461A1 (en) |
| CN (1) | CN104203228A (en) |
| SG (1) | SG11201405018VA (en) |
| WO (1) | WO2013147585A1 (en) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MX2018009543A (en) * | 2016-02-03 | 2019-02-11 | Quercegen Pharmaceuticals Llc | Method for treating zika virus infection with quercetin-containing compositions. |
| US10987371B2 (en) * | 2017-06-09 | 2021-04-27 | Adaerata, Limited Partnership | Methods of preventing or treating filovirus and flavivirus diseases |
| WO2019185579A1 (en) * | 2018-03-27 | 2019-10-03 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Use of quercetin-3-o-glucoside for the treatment of flavivirus infections |
| EP3909578A1 (en) * | 2020-05-12 | 2021-11-17 | Universidad de Castilla la Mancha | Antiviral composition comprising eeyarestatin i |
| CN113082128B (en) * | 2021-04-12 | 2022-05-03 | 南方医科大学 | Ampelopsis japonica extract, preparation method thereof and application of ampelopsis japonica extract in preventing and treating dengue fever type II virus infection |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AP1691A (en) * | 1999-08-23 | 2006-12-11 | Immune Balance Tech Limited Company | A pharmaceutical composition comprising therapeutically effective quantities of calcium channel blockers in combination with quinolines. |
| AU2008256727A1 (en) * | 2007-05-23 | 2008-12-04 | Siga Technologies, Inc. | Antiviral drugs for treatment or prevention of dengue infection |
| CA2712195C (en) * | 2008-01-18 | 2016-12-06 | Thomas Christian Lines | Method for treating addiction using quercetin-containing compositions |
| CN102343083A (en) * | 2011-10-17 | 2012-02-08 | 中国科学院成都生物研究所 | Antivirus composition medicament |
-
2013
- 2013-01-31 SG SG11201405018VA patent/SG11201405018VA/en unknown
- 2013-01-31 WO PCT/MY2013/000019 patent/WO2013147585A1/en active Application Filing
- 2013-01-31 US US14/384,373 patent/US20150080461A1/en not_active Abandoned
- 2013-01-31 CN CN201380018575.XA patent/CN104203228A/en active Pending
-
2015
- 2015-09-15 US US14/854,194 patent/US20160000749A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| US20160000749A1 (en) | 2016-01-07 |
| WO2013147585A1 (en) | 2013-10-03 |
| CN104203228A (en) | 2014-12-10 |
| US20150080461A1 (en) | 2015-03-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1245263A1 (en) | Antiviral compounds | |
| HK1205484A1 (en) | Printhead stiffening | |
| SG10201703451RA (en) | Antiviral compounds | |
| HK1214242A1 (en) | Benzamides | |
| PL3205211T3 (en) | Alcohol-based antiviral composition | |
| PL2879805T3 (en) | Nozzle arrangement | |
| EP2825475A4 (en) | Nozzle | |
| HK1204618A1 (en) | Antiviral compounds | |
| SG11201405018VA (en) | A composition having antiviral activity against flavivirus | |
| HK1210165A1 (en) | Methanethione compounds having antiviral activity | |
| HK1206745A1 (en) | Schweinfurthin analogues schweinfurthin | |
| SG11201405016TA (en) | Antiviral composition against flavivirus | |
| EP2664621A4 (en) | Antiviral agent | |
| EP2691106A4 (en) | Antiviral composition | |
| GB201219713D0 (en) | A collapsableinfant chair | |
| GB201219961D0 (en) | Ink | |
| ZA201306909B (en) | Antiviral composition | |
| GB201121309D0 (en) | Antiviral | |
| GB201215548D0 (en) | A composition | |
| GB201214365D0 (en) | Enhanced activity catalyst composition | |
| EP2929195A4 (en) | Attachment arrangement | |
| GB201209601D0 (en) | A nozzle attachment | |
| HK1173898A2 (en) | Suit | |
| GB201220636D0 (en) | A hand santiser | |
| GB201207262D0 (en) | Medicaments |